SG158068A1 - Polymorphs of sarsapogenin - Google Patents
Polymorphs of sarsapogeninInfo
- Publication number
- SG158068A1 SG158068A1 SG200907351-1A SG2009073511A SG158068A1 SG 158068 A1 SG158068 A1 SG 158068A1 SG 2009073511 A SG2009073511 A SG 2009073511A SG 158068 A1 SG158068 A1 SG 158068A1
- Authority
- SG
- Singapore
- Prior art keywords
- sarsapogenin
- polymorphs
- sarsasapogenin
- solvated
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424528A GB0424528D0 (en) | 2004-11-05 | 2004-11-05 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG158068A1 true SG158068A1 (en) | 2010-01-29 |
Family
ID=33523268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200907351-1A SG158068A1 (en) | 2004-11-05 | 2005-11-04 | Polymorphs of sarsapogenin |
Country Status (17)
Country | Link |
---|---|
US (1) | US20080194530A1 (zh) |
EP (2) | EP2479183A3 (zh) |
JP (1) | JP2008519020A (zh) |
KR (1) | KR20070089798A (zh) |
CN (2) | CN101068827B (zh) |
AU (1) | AU2005300348A1 (zh) |
BR (1) | BRPI0517648A (zh) |
CA (1) | CA2584676A1 (zh) |
GB (1) | GB0424528D0 (zh) |
IL (1) | IL182879A0 (zh) |
MX (1) | MX2007005473A (zh) |
NO (1) | NO20072794L (zh) |
RU (1) | RU2007119611A (zh) |
SG (1) | SG158068A1 (zh) |
TW (1) | TW200635941A (zh) |
WO (1) | WO2006048665A2 (zh) |
ZA (1) | ZA200703630B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012515754A (ja) | 2009-01-24 | 2012-07-12 | ファイトファーム ピーエルシー | 神経栄養因子介在疾患の治療 |
WO2012010896A1 (en) | 2010-07-20 | 2012-01-26 | Phytopharm Plc | Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders |
JP5881525B2 (ja) * | 2011-05-16 | 2016-03-09 | ライオン株式会社 | サポゲニン安定化組成物の製造方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2306635A (en) * | 1940-08-03 | 1942-12-29 | Parke Davis & Co | Method for the preparation of steroidal carbinols |
US2408827A (en) * | 1944-05-15 | 1946-10-08 | Parke Davis & Co | Steroidal compounds and methods for obtaining the same |
US2774714A (en) * | 1952-10-10 | 1956-12-18 | Emanuel B Hershberg | Process for the extraction of sapogenins from plant materials |
US3019220A (en) * | 1958-07-17 | 1962-01-30 | Julian Lab Inc | Isolation of sapogenins |
US4057543A (en) * | 1976-07-01 | 1977-11-08 | G. D. Searle & Co. | Process for the preparation of 17β-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone |
US4680289A (en) * | 1985-06-05 | 1987-07-14 | Progenics, Inc. | Treatment of obesity and diabetes using sapogenins |
JPH04230696A (ja) * | 1990-12-28 | 1992-08-19 | Sanwa Shiyouyaku Kk | 新規なステロイド系化合物および制癌剤 |
CN1033754C (zh) * | 1993-05-31 | 1997-01-08 | 上海第二医科大学 | 知母皂甙元作为制备β肾上腺素和M胆碱受体双向调节药的用途及其制法 |
KR100217996B1 (ko) * | 1996-12-23 | 1999-09-01 | 윤종용 | 프린트 헤드의 노즐 간격 보상 장치 및 방법 |
JP2003524581A (ja) | 1998-03-26 | 2003-08-19 | ファイトファーム・ピーエルシー | アルツハイマー病の治療のためのスミラゲニン及びアンズロゲニン−d |
GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB0000228D0 (en) | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
AT409100B (de) | 2000-07-24 | 2002-05-27 | Evg Entwicklung Verwert Ges | Vorrichtung zum schweissen einer drahtgittermatte |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
IL164161A0 (en) | 2002-03-27 | 2005-12-18 | Phytopharm Plc | Therapeutic methods and uses of sapogenins and their derivatives |
-
2004
- 2004-11-05 GB GB0424528A patent/GB0424528D0/en not_active Ceased
-
2005
- 2005-11-04 KR KR1020077012720A patent/KR20070089798A/ko not_active Application Discontinuation
- 2005-11-04 EP EP11155897.9A patent/EP2479183A3/en not_active Withdrawn
- 2005-11-04 AU AU2005300348A patent/AU2005300348A1/en not_active Abandoned
- 2005-11-04 JP JP2007539637A patent/JP2008519020A/ja active Pending
- 2005-11-04 RU RU2007119611/04A patent/RU2007119611A/ru not_active Application Discontinuation
- 2005-11-04 SG SG200907351-1A patent/SG158068A1/en unknown
- 2005-11-04 TW TW094138749A patent/TW200635941A/zh unknown
- 2005-11-04 US US11/667,035 patent/US20080194530A1/en not_active Abandoned
- 2005-11-04 CN CN200580037705XA patent/CN101068827B/zh not_active Expired - Fee Related
- 2005-11-04 BR BRPI0517648-4A patent/BRPI0517648A/pt not_active IP Right Cessation
- 2005-11-04 EP EP05799915A patent/EP1809650A2/en not_active Withdrawn
- 2005-11-04 CA CA002584676A patent/CA2584676A1/en not_active Abandoned
- 2005-11-04 CN CN2011100921741A patent/CN102219826A/zh active Pending
- 2005-11-04 MX MX2007005473A patent/MX2007005473A/es unknown
- 2005-11-04 WO PCT/GB2005/004266 patent/WO2006048665A2/en active Application Filing
-
2007
- 2007-04-30 IL IL182879A patent/IL182879A0/en unknown
- 2007-05-04 ZA ZA200703630A patent/ZA200703630B/xx unknown
- 2007-06-01 NO NO20072794A patent/NO20072794L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101068827A (zh) | 2007-11-07 |
IL182879A0 (en) | 2007-08-19 |
CN102219826A (zh) | 2011-10-19 |
WO2006048665A3 (en) | 2006-09-08 |
KR20070089798A (ko) | 2007-09-03 |
WO2006048665A2 (en) | 2006-05-11 |
ZA200703630B (en) | 2009-10-28 |
US20080194530A1 (en) | 2008-08-14 |
EP2479183A3 (en) | 2013-08-28 |
EP1809650A2 (en) | 2007-07-25 |
MX2007005473A (es) | 2007-05-24 |
AU2005300348A1 (en) | 2006-05-11 |
BRPI0517648A (pt) | 2008-10-14 |
RU2007119611A (ru) | 2008-12-10 |
CN101068827B (zh) | 2011-06-08 |
GB0424528D0 (en) | 2004-12-08 |
CA2584676A1 (en) | 2006-05-11 |
EP2479183A2 (en) | 2012-07-25 |
NO20072794L (no) | 2007-07-31 |
JP2008519020A (ja) | 2008-06-05 |
TW200635941A (en) | 2006-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI347844B (en) | Sulfoximine-substituted pyrimidines as cdk-and/or vegf inhibitors, their production and use as pharmaceutical agents | |
WO2006071862A3 (en) | Polymorphs of 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate | |
AP2327A (en) | Quinoline derivatives for the treatment of latent tuberculosis. | |
EP1948852A4 (en) | REFERENCE ELECTRODE AND METHOD FOR PRODUCING THE REFERENCE ELECTRODE | |
WO2007037849A3 (en) | Compositions and methods for the intraocular transport of therapeutic agents | |
IL179758A (en) | Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof and use of the same as medicaments | |
IL180680A0 (en) | Piperazine derivatives useful for the treatment of gastrointestinal disorders | |
EP1863769A4 (en) | HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS | |
IL185484A0 (en) | Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents | |
PL1928840T3 (pl) | 1H-pirazolo-4-karboksyamidy, ich wytwarzanie i ich zastosowanie jako inhibitory dehydrogenazy 11-beta-hydroksysteroidowej | |
PT1922309E (pt) | Derivados de n-fenil-2-pirimidina-amina e processo para a sua preparação | |
NL1029045A1 (nl) | Pyrimidinederivaten voor de behandeling van abnormale celgroei. | |
AU2006321904A8 (en) | 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors | |
EP1951681A4 (en) | NEW 2-AMINOPYRIMIDINE DERIVATIVES AND THEIR USE | |
EP1720893A4 (en) | COMPOSITIONS AND METHODS FOR SYSTEMIC TREATMENT OF ARTHRITIS | |
WO2006116311A3 (en) | Opioid receptor agonist compounds and their use in treatment of pain | |
PL1786759T3 (pl) | Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie | |
SG158068A1 (en) | Polymorphs of sarsapogenin | |
GB0417803D0 (en) | Algorithmic trading | |
SG155165A1 (en) | Crystalline and amorphous forms of smilagenin | |
IL182951A0 (en) | Enhancer of the effect of adrenocorticoid, comprising gum arabic | |
WO2008021518A3 (en) | Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride | |
GB0418858D0 (en) | Double stud fitting | |
WO2003099783A3 (en) | Tropane compounds | |
AU2006315663A8 (en) | KIFS as modifiers of the RHO pathway and methods of use |